NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Kura Oncology, Inc. Share Price Chart

O H L

Kura Oncology, Inc. Performance Overview

Days Range
$11.63Low
$11.74High

Markets Today

Previous Close$11.72
Open$11.66
Volume162,784
Day's Range$11.63 - $11.74
52W Range$7.36 - $13.90
Market Cap$996.36 M

Historical Performance

1M Returns-4.95
3M Returns+18.03
6M Returns+39.69
1Y Returns+38.86
5Y Returns-44.08
10Y Returns+67.67

Kura Oncology, Inc. Fundamentals

Market Cap$996.36 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$67.48 M
ROE TTM-0.95
EPS TTM$-3.36
Quarterly Earnings Growth YOYN/A
PB Ratio20.57
EBITDA$-302.60 M
Profit Margin-412.95
Market Cap$996.36 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$67.48 M
ROE TTM-0.95
EPS TTM$-3.36
Quarterly Earnings Growth YOYN/A
PB Ratio20.57
EBITDA$-302.60 M
Profit Margin-412.95

Kura Oncology, Inc. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$14.11 M$15.29 M$20.75 M$17.34 M$18.27 M$20.87 M
Gross Profit +$14.11 M$15.29 M$20.75 M$17.28 M$18.00 M$20.63 M
Operating Income -$64.70 M-$72.67 M-$80.00 M-$86.27 M-$78.81 M-$73.01 M
EBITDA -$64.46 M-$72.44 M-$79.83 M-$85.86 M-$78.46 M-$72.64 M
Interest Expense -$382.00 K-$391.00 K-$393.00 K-$346.00 K-$336.00 K-$345.00 K
Depreciation $241.00 K$224.00 K$164.00 K$403.00 K$355.00 K$369.00 K
Income Before Tax -$57.20 M-$66.12 M-$74.12 M-$80.93 M-$73.33 M-$68.32 M
Income Tax Expense $226.00 K$0$0$71.00 K$8.00 K$5.00 K
Net Income +-$57.43 M-$66.12 M-$74.12 M-$81.00 M-$73.33 M-$68.33 M
Net Profit Margin -407.07%-432.51%-357.19%-467.23%-401.49%-327.33%

Kura Oncology, Inc. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $8.00 K$9.00 K$9.00 K$9.00 K$9.00 K$9.00 K
Reserve & Surplus -$951.88 M-$1.02 B-$1.09 B-$1.17 B-$1.25 B-$1.32 B
Non-Current Liabilities $289.59 M$269.76 M$285.54 M$447.25 M$443.17 M$421.17 M
Current Liabilities $89.77 M$107.17 M$121.30 M$116.97 M$101.50 M$118.19 M
Total Liabilities $379.36 M$376.94 M$406.84 M$564.23 M$544.67 M$539.36 M
Fixed Assets $2.35 M$3.91 M$7.40 M$7.86 M$7.61 M$7.59 M
Current Assets $724.20 M$660.08 M$620.66 M$708.66 M$623.78 M$559.44 M
Total Assets $743.76 M$682.42 M$649.38 M$738.36 M$652.55 M$587.79 M

Kura Oncology, Inc. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$57.43 M-$66.12 M-$74.12 M-$81.00 M-$73.33 M-$68.33 M
Operating Cash Flow -$71.93 M-$28.78 M-$80.63 M$117.27 M-$85.85 M-$62.55 M
Investing Cash Flow -$101.41 M$58.94 M$93.97 M-$64.60 M-$24.23 M$92.21 M
Financing Cash Flow $143.00 K$515.00 K$0$1.14 M$69.00 K$1.50 M
Change in Cash -$173.19 M$30.68 M$13.34 M$53.81 M-$110.02 M$31.16 M

Kura Oncology, Inc. Return Calculator

The Kura Oncology, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$5,534
Invested Amount$10,000
Est. Returns$-4,466
Invest in USA Stock Today

About Kura Oncology, Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

FAQs

Kura Oncology, Inc. (KURA) share price as of September 18, 2026 is $11.60. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Kura Oncology, Inc. (KURA) Share by opening an international trading account with Angel One.
Purchasing Kura Oncology, Inc. (KURA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Kura Oncology, Inc. (KURA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Kura Oncology, Inc. (KURA) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Kura Oncology, Inc. on September 18, 2026, is $996.36 M.
Kura Oncology, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Kura Oncology, Inc. (KURA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91